|
2024
|
Invention
|
Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha-emitting radioimm... |
|
|
Invention
|
Methods for treatment of patients with myelodysplastic syndromes.
Methods for treating a prolife... |
|
|
Invention
|
Combination therapies for the treatment of cd33-positive hematological malignancies harboring mut... |
|
|
Invention
|
Multi-arm bifunctional chelators. Provided are new multi-arm bifunctional chelators for use in th... |
|
|
Invention
|
Humanized anti-cd45 antibodies.
Provided are humanized anti-human CD45 antibodies and pharmaceut... |
|
|
Invention
|
Calreticulin nanobodies. Provided are nanobodies that bind human calreticulin, fusion proteins in... |
|
|
Invention
|
Bifunctional chelators and conjugates.
Provided are new bifunctional chelators for use in the ma... |
|
|
Invention
|
Anti-cd45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based ... |
|
2023
|
Invention
|
Her3 radioimmunotherapy for the treatment of solid cancers. Provided are compositions and methods... |
|
|
Invention
|
Method for treating cancer using a bcl-2 inhibitor in conjunction with an alpha- emitting radioim... |
|
|
Invention
|
Bifunctional chelators and conjugates. Provided are new bifunctional chelators for use in the man... |
|
|
Invention
|
Humanized anti-cd45 antibodies. Provided are humanized anti-human CD45 antibodies or antibody fra... |
|
|
Invention
|
Humanized anti-cd45 antibodies. Provided are humanized anti-human CD45 antibodies and pharmaceuti... |
|
|
Invention
|
Calreticulin nanobodies.
Provided are nanobodies that bind human calreticulin, fusion proteins i... |
|
|
Invention
|
Grp78 nanobodies. Provided are nanobodies that recognize human cell surface GRP78 protein, pharma... |
|
|
Invention
|
Her3 nanobodies. Provided are anti-huHER3 nanobody or a fusion proteins, including an anti-huHER3... |
|
|
Invention
|
Methods for treating cd33-positive hematological malignancies.
Provided are methods for treating... |
|
|
Invention
|
Methods for treating cd33-positive hematological malignancies. Provided are methods for treating ... |
|
2022
|
Invention
|
Her3 radioimmunotherapy for the treatment of solid cancers.
Provided are compositions and method... |
|
|
Invention
|
Radioimmunoconjugates targeting grp78 for use in the treatment of cancer.
Methods for treating c... |
|
|
Invention
|
Radioconjugates targeting grp78 for use in the treatment of cancer. Methods for treating cancers ... |
|
|
Invention
|
Radioimmunoconjugates targeting grp78 for use in the treatment of cancer. Methods for treating ca... |
|
|
P/S
|
Medicinal preparations for use in oncology
Pharmaceutical preparations and substances for the tre... |
|
|
Invention
|
Radioimmunoconjugates targeting phosphatidylserine for use in the treatment of cancer. Methods fo... |
|
|
Invention
|
Radioconjugates targeting cd33 in the treatment of cancers. The invention provides compositions a... |
|
|
Invention
|
Radioimmunoconjugates targeting calreticulin for use in the treatment of cancer.
Methods for tre... |
|
|
Invention
|
Radioimmunoconjugates targeting calreticulin for use in the treatment of cancer. Methods for trea... |
|
|
Invention
|
Radioconjugates targeting cd33 in the treatment of cancers.
The invention provides compositions ... |
|
|
P/S
|
Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a prepara... |
|
|
P/S
|
Pharmaceutical preparations for use in oncology
Pharmaceutical preparations for use in a preparat... |
|
|
Invention
|
Radioimmunoconjugates directed to nkg2d ligands for the treatment of cancer.
Provided are compos... |
|
|
Invention
|
Radioimmunoconjugates directed to nkg2d ligands for the treatment of cancer. Provided are composi... |
|
|
Invention
|
Combination radioimmunotherapy and cd47 blockade in the treatment of cancer.
Provided are compos... |
|
|
Invention
|
Combination radioimmunotherapy and cd47 blockade in the treatment of cancer. Provided are composi... |
|
|
Invention
|
Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cells.
Prov... |
|
|
Invention
|
Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cells. Provi... |
|
|
Invention
|
Low dose antibody-based methods for treating hematologic malignancies.
This invention provides a... |
|
2021
|
Invention
|
Trophoblast glycoprotein radioimmunotherapy for the treatment of solid cancers.
Compositions and... |
|
|
Invention
|
Method for treating acute myeloid leukemia using venetoclax in conjunction with lintuzumab-ac225.... |
|
|
Invention
|
Dr5 radioimmunotherapy in the treatment of solid cancers.
Methods for treating a proliferative d... |
|
2020
|
Invention
|
Radiolabeling of anti-cd45 immunoglobulin and methods of use thereof.
Compositions and methods u... |
|
|
Invention
|
Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hema... |
|
2018
|
Invention
|
Combination therapy for treatment of a hematological disease.
Methods for treating a hematologic... |
